Legislator Case Law & Legislation
ln_2021_111 MT

Third Schedule) Regulations, 2021

4 Articles / Provisions · Malta
Open official source Machine-readable Markdown (.md)

Statutory Text (4 Articles)

Malta Government Gazette — Legal Notice 2021 111 · Gazzetta tal-Gvern ta’ Malta Nru. 20,591 – 17.03.2021<P Class=Msonormal — Third Schedule) Regulations, 2021

L.N. 111 of 2021

MEDICAL AND KINDRED PROFESSIONS ORDINANCE

(CAP. 31)

Medical and Kindred Professions Ordinance (Amendment of

Third Schedule) Regulations, 2021

IN EXERCISE of the powers conferred by article 40A of the

Medical and Kindred Professions Ordinance, the Minister for Health

after consultation with the Council of Health, has made the following

regulations:-

Malta Government Gazette — Legal Notice 2021 111 · Gazzetta tal-Gvern ta’ Malta Nru. 20,591 – 17.03.2021<P Class=Msonormal — Third Schedule) Regulations, 2021

The title of these regulations is Medical and Kindred Citation.

Professions Ordinance (Amendment of Third Schedule) Regulations,

2021 and these regulations shall be read and construed as one with the

Third Schedule to the Medical and Kindred Professions Ordinance, Cap. 31.

which Third Schedule is hereinafter in these regulations referred to as

"the Third Schedule".

Malta Government Gazette — Legal Notice 2021 111 · Gazzetta tal-Gvern ta’ Malta Nru. 20,591 – 17.03.2021<P Class=Msonormal — Third Schedule) Regulations, 2021

In Part A of the Third Schedule, there shall be added the Amends Part A

of the Third

following

Schedule.

International or other

nonproprietary name or

Chemical name

other trivial name

"DOC

1-(4-chloro-2,5-dimethoxyphenyl)propan-

2-amine".

Malta Government Gazette — Legal Notice 2021 111 · Gazzetta tal-Gvern ta’ Malta Nru. 20,591 – 17.03.2021<P Class=Msonormal — Third Schedule) Regulations, 2021

In Part B of the Third Schedule, there shall be added the Amends Part B

of the Third

following

Schedule.

International or other

nonproprietary name or

Chemical name

other trivial name

"AB-FUBINACA (or

N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-

FUB-AMB)

(4-fluorobenzyl)-1H-indazole-3-carboxam-

ide

5F-AMB-PINACA (or 5F- methyl 2-({[1-(5-fluoropentyl)-1H-indazole-

3-yl]carbonyl}amino)-3-methylbutanoate

AMB or 5F-MMB-PIN-

ACA)

5F-MDMB-PICA (or 5F- methyl 2-{[1-(5-fluoropentyl)-1H-indole-3-

MDMB-2201)

carbonyl]amino}-3,3-dimethylbutanoate

4F-MDMB-BINACA (or

methyl 2-{[1-(4-fluorobutyl)-1H-indazole-3-

4F-MDMB-BUTINACA)

carbonyl]amino}-3,3-dimethylbutanoate

4-CMC (or 4-chlorometh-

1-(4-chlorophenyl)-2-(methylamino)pro-

cathinone or clephedrone)

pan-1-one

N-ethylhexedrone (or

2-(ethylamino)-1-phenylhexan-1-one

NEH, Hexen, Ethyl-Hex,

Ethyl-hexedrone)

Alpha-PHP (or PV-7, α-

1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one

PHP, α-pyrrolidinohexan-

ophenone)

8-chloro-6-(2-fluorophenyl)-1-methyl-4H-

Flualprazolam (or Ro 11-

[1,2,4]triazolo[4,3-a][1,4]benzodiazepine

5073/000)

Etizolam (or Y-7131 or

4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-

thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diaze-

Depas)

pine".

€0.18

Need to analyze how this provision applies to your matter?

Cross-reference this statute against case law, commentaries, and related legislative provisions inside Legislator AI.

Open in Legislator →